453 related articles for article (PubMed ID: 10575442)
1. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer.
Sardanelli F; Losacco C; Iozzelli A; Renzetti P; Rosso E; Parodi RC; Bonetti M; Murialdo A
Eur Radiol; 2002 Aug; 12(8):2077-82. PubMed ID: 12136326
[TBL] [Abstract][Full Text] [Related]
3. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
Mathews VP; Caldemeyer KS; Lowe MJ; Greenspan SL; Weber DM; Ulmer JL
Radiology; 1999 Apr; 211(1):257-63. PubMed ID: 10189481
[TBL] [Abstract][Full Text] [Related]
4. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
Petersein J; Spinazzi A; Giovagnoni A; Soyer P; Terrier F; Lencioni R; Bartolozzi C; Grazioli L; Chiesa A; Manfredi R; Marano P; Van Persijn Van Meerten EL; Bloem JL; Petre C; Marchal G; Greco A; McNamara MT; Heuck A; Reiser M; Laniado M; Claussen C; Daldrup HE; Rummeny E; Kirchin MA; Pirovano G; Hamm B
Radiology; 2000 Jun; 215(3):727-36. PubMed ID: 10831691
[TBL] [Abstract][Full Text] [Related]
5. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
6. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
8. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
9. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
[TBL] [Abstract][Full Text] [Related]
10. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
Carvlin MJ; De Simone DN; Meeks MJ
Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
[TBL] [Abstract][Full Text] [Related]
12. Imaging of active multiple sclerosis plaques: efficiency of contrast-enhanced magnetization transfer subtraction technique.
Algin O; Hakyemez B; Taşkapilioğlu O; Parlak M; Turan F
Diagn Interv Radiol; 2010 Jun; 16(2):106-11. PubMed ID: 20309819
[TBL] [Abstract][Full Text] [Related]
13. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
[TBL] [Abstract][Full Text] [Related]
15. Cerebral infarction: effects of dose and magnetization transfer saturation at gadolinium-enhanced MR imaging.
Mathews VP; King JC; Elster AD; Hamilton CA
Radiology; 1994 Feb; 190(2):547-52. PubMed ID: 8284414
[TBL] [Abstract][Full Text] [Related]
16. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T.
Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB
Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514
[TBL] [Abstract][Full Text] [Related]
18. Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy ME; Hesselink JR; Press GA; Middleton MS
Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
[TBL] [Abstract][Full Text] [Related]
19. [Detectability of metastatic brain tumors using gadoteridol-enhanced MRI: usefulness of standard-dose T1-weighted spin-echo image with magnetization transfer and enhanced FLAIR].
Annoura K; Utsunomiya H; Arai S; Okazaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Mar; 60(3):77-82. PubMed ID: 10741113
[TBL] [Abstract][Full Text] [Related]
20. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]